GlaxoSmithKline Plc (Mexico) Insiders
| GSKN Stock | MXN 739.40 0.57 0.08% |
GlaxoSmithKline Plc employs about 45 people. The company is managed by 10 executives with a total tenure of roughly 28 years, averaging almost 2.0 years of service per executive, having 4.5 employees per reported executive. Break down of GlaxoSmithKline Plc's management performance can provide insight into the company performance.
| Emma Walmsley President President - Consumer Healthcare Worldwide |
GlaxoSmithKline |
GlaxoSmithKline Plc Management Team Effectiveness
The company has return on total asset (ROA) of 0.0659 % which means that it generated a profit of $0.0659 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3131 %, meaning that it generated $0.3131 on every $100 dollars invested by stockholders. GlaxoSmithKline Plc's management efficiency ratios could be used to measure how well GlaxoSmithKline Plc manages its routine affairs as well as how well it operates its assets and liabilities.GlaxoSmithKline Plc Workforce Comparison
GlaxoSmithKline plc is one of the top stocks in number of employees category among its peers. The total workforce of Drug Manufacturers—General industry is currently estimated at about 218,860. GlaxoSmithKline Plc adds roughly 45.0 in number of employees claiming only tiny portion of equities under Drug Manufacturers—General industry.
The company has Profit Margin (PM) of 0.51 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.25 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.25. GlaxoSmithKline plc Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. GlaxoSmithKline plc Price Series Summation is a cross summation of GlaxoSmithKline Plc price series and its benchmark/peer.
GlaxoSmithKline Plc Notable Stakeholders
A GlaxoSmithKline Plc stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as GlaxoSmithKline Plc often face trade-offs trying to please all of them. GlaxoSmithKline Plc's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting GlaxoSmithKline Plc's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Emma Walmsley | President - Consumer Healthcare Worldwide | Profile | |
| Iain Mackay | CFO - Designate, Executive Director | Profile | |
| David Redfern | Chief Strategy Officer | Profile | |
| Diana Conrad | Chief Officer | Profile | |
| Sally Jackson | VP Office | Profile | |
| James Ford | Sr Compliance | Profile | |
| Shobie Ramakrishnan | Chief Officer | Profile | |
| Sarah EltonFarr | Head Relations | Profile | |
| Julie Brown | Chief Officer | Profile | |
| Tony Wood | Chief Officer | Profile |
About GlaxoSmithKline Plc Management Performance
The success or failure of an entity such as GlaxoSmithKline plc often depends on how effective the management is. GlaxoSmithKline Plc management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of GlaxoSmithKline management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the GlaxoSmithKline management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom. GLAXOSMITHKLINE is traded on Mexico Stock Exchange in Mexico.
Please note, the imprecision that can be found in GlaxoSmithKline Plc's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of GlaxoSmithKline plc. Check GlaxoSmithKline Plc's Beneish M Score to see the likelihood of GlaxoSmithKline Plc's management manipulating its earnings.
GlaxoSmithKline Plc Workforce Analysis
Traditionally, organizations such as GlaxoSmithKline Plc use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare GlaxoSmithKline Plc within its industry.GlaxoSmithKline Plc Manpower Efficiency
Return on GlaxoSmithKline Plc Manpower
| Revenue Per Employee | 651.6M | |
| Revenue Per Executive | 2.9B | |
| Net Income Per Employee | 332.4M | |
| Net Income Per Executive | 1.5B | |
| Working Capital Per Employee | 42.4M | |
| Working Capital Per Executive | 191M |
Additional Tools for GlaxoSmithKline Stock Analysis
When running GlaxoSmithKline Plc's price analysis, check to measure GlaxoSmithKline Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GlaxoSmithKline Plc is operating at the current time. Most of GlaxoSmithKline Plc's value examination focuses on studying past and present price action to predict the probability of GlaxoSmithKline Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GlaxoSmithKline Plc's price. Additionally, you may evaluate how the addition of GlaxoSmithKline Plc to your portfolios can decrease your overall portfolio volatility.